🔎 Trials Near Me

Home › Acute Myeloid Leukemia › New Jersey › Newark

Acute Myeloid Leukemia clinical trials in Newark, NJ

12 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Newark (within about 30 miles). Open a study to see who can join and how to contact the study team.

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • Cooperman Barnabas Medical Center, Livingston · 9 mi away
Ages 18 to 59 · All sexes · Updated Sep 28, 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RecruitingPhase 2
  • Cooperman Barnabas Medical Center, Livingston · 9 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05564390

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • Cooperman Barnabas Medical Center, Livingston · 9 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06672146

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • Cooperman Barnabas Medical Center, Livingston · 9 mi away
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06317649

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RecruitingPhase 2
  • Cooperman Barnabas Medical Center, Livingston · 9 mi away
Ages 18 to 59 · All sexes · Updated Sep 22, 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RecruitingPhase 3
  • Newark Beth Israel Medical Center, Newark
  • Morristown Medical Center, Morristown · 17 mi away
6 Months – 21 Years · All sexes · Updated Sep 17, 2026 · NCT04293562

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

RecruitingPhase 1/2
  • Atlantic Health, Morristown · 17 mi away
Ages 12 and older · All sexes · Updated Sep 3, 2026 · NCT04588922

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Morristown Medical Center, Morristown · 17 mi away
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

RecruitingPhase 3
  • Morristown Medical Center, Morristown · 17 mi away
29 Days – 21 Years · All sexes · Updated Aug 24, 2026 · NCT05183035

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

RecruitingPhase 2/3
  • Atlantic Health, Morristown · 17 mi away
Ages 18 to 80 · All sexes · Updated Aug 5, 2026 · NCT06788756

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

RecruitingPhase 1/2
  • Atlantic Health, Morristown · 17 mi away
Ages 12 and older · All sexes · Updated Mar 24, 2026 · NCT04988555

About Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.

More about Acute Myeloid Leukemia on MedlinePlus

Acute Myeloid Leukemia trials in other cities

Other studies in Newark

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.